Sensenbrenner Primary Care — Charlotte, North Carolina

Sensenbrenner Primary Care is a clinical research site located in Charlotte, North Carolina, United States 28277.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Sensenbrenner Primary Care has participated in 9 clinical trials.

Therapeutic areas: Cardiovascular Disease, Diabetes Type 2, Type 1 Diabetes.

Sponsors: Pfizer, Mannkind Corporation, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sensenbrenner Primary Care?

Sensenbrenner Primary Care has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sensenbrenner Primary Care conducted?

Sensenbrenner Primary Care has 9 clinical trials on record. Their work covers Cardiovascular Disease, Diabetes Type 2, Type 1 Diabetes.

Is Sensenbrenner Primary Care accredited by Crixeo Clinical Trials?

Sensenbrenner Primary Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sensenbrenner Primary Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.